Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 11/20 | 0.43 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.42 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | GLP1R | P43220 | 2/20 | 0.40 |
| ▸ | SCTR | P47872 | 1/20 | 0.40 |
| ▸ | CALCR | P30988 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29514698 | 1.00 | BACE1 (0.43) | BACE1BACE2C5AR1OPRD1CTSD | |
| SCHEMBL29514645 | 0.98 | BACE1 (0.44) | BACE1BACE2C5AR1OPRD1CTSD | |
| SCHEMBL29808308 | 0.91 | C5AR1 (0.41) | BACE1BACE2C5AR1CTSDGLP1R | |
| SCHEMBL29514780 | 0.90 | BACE1 (0.41) | BACE1BACE2OPRD1CTSD | |
| SCHEMBL29940718 | 0.90 | BACE1 (0.46) | BACE1BACE2CTSD | |
| SCHEMBL31031469 | 0.87 | BACE1 (0.52) | BACE1BACE2C5AR1OPRD1GLP1R | |
| SCHEMBL30441425 | 0.87 | SLC15A2 (0.43) | BACE1BACE2C5AR1CTSD | |
| SCHEMBL30093349 | 0.87 | GLP1R (0.41) | C5AR1GLP1RSCTR | |
| SCHEMBL29530561 | 0.87 | SLC15A2 (0.39) | C5AR1GLP1RSCTRCALCR | |
| SCHEMBL10695762 | 0.86 | CCNA2 (0.46) | BACE1BACE2GLP1RCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621318-A | Peptide therapy for inflammation and fibrosis | 加利福尼亚大学董事会 | 2022-06-14 | — | — | CN | claimed |
| CN-114181281-A | Peptide therapy for inflammation and fibrosis | 加利福尼亚大学董事会 | 2022-03-15 | — | — | CN | claimed |
| CN-114621318-A | Peptide therapy for inflammation and fibrosis | 加利福尼亚大学董事会 | 2022-06-14 | — | — | CN | disclosed |
| CN-107531752-B | Peptide therapy for inflammation and fibrosis | 加利福尼亚大学董事会 | 2022-05-10 | — | — | CN | disclosed |
| CN-114181281-A | Peptide therapy for inflammation and fibrosis | 加利福尼亚大学董事会 | 2022-03-15 | — | — | CN | disclosed |